Healthcare


Analysis of the European HIV Drugs Market

This research service provides an in-depth analysis of the HIV drugs market across Europe. It analyses the revenue potential, market dynamics, trends, and the competitive structure. The revenue values of the European HIV drugs market have been derived from market sales and pipeline investment made under drug classes like nucleoside reverse transcriptase inhibitors, protease inhibitors, non-nucleoside reverse transcriptase inhibitors and integrase inhibitors. The market analysed in this research service has been approached from a manufacturer's point of view. Apart from segmentation by drug classes, the market has also been broken down based on major Western European countries.
Published: 23 Jan 2013

Analysis of the European HIV Drugs Market

Increasing Adoption of Oral Combination-pills for Treatment Boosts Market Growth

This research service provides an in-depth analysis of the HIV drugs market across Europe. It analyses the revenue potential, market dynamics, trends, and the competitive structure. The revenue values of the European HIV drugs market have been derived from market sales and pipeline investment made under drug classes like nucleoside reverse transcriptase inhibitors, protease inhibitors, non-nucleoside reverse transcriptase inhibitors and integrase inhibitors. The market analysed in this research service has been approached from a manufacturer's point of view. Apart from segmentation by drug classes, the market has also been broken down based on major Western European countries.

Key Questions This Study Will Answer

  • What are the key factors driving the market, and restraints that need to be addressed?
  • What is the current disease scenario across the HIV therapeutics market in Europe?
  • Which are the major market segments, and what are the important trends?
  • Who are the key market participants across the HIV drugs market, and where do they stand?
  • What is the state of the HIV policy system across different regions in Europe, and what will be it’s impact on the market in the future?
  • What is the future of the HIV drugs market in Europe and how it will impact HIV drug manufacturers?

Features of this Research

Help Desk

Full list of offices


For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..